Corentin Beaumal, Ph.D.

Corentin obtained his Master’s Degree and PhD in Analytical Sciences from the University of Strasbourg, France. His PhD work focused on the development of MS analytical and bioinformatics strategies for the characterization of therapeutic proteins and their impurities. Corentin joined the Characterisation and Comparability Lab at NIBRT early 2024 as part of the collaborative project funded by Thermo Fisher Scientific for the development of cutting-edge LC-MS analytical methods to characterize novel biotherapeutics, including monoclonal antibodies, fusion proteins and adeno-associated viruses (AAVs).